Breadcrumb

  1. Insights
  2. Alerts

Alerts

5229 total results. Page 3 of 210.

Abha Kundi*, Nardeen Billan

Everyone is talking about peptides. Your doctor, your trainer, that guy at the dinner party who swears that BPC-157 rebuilt his knee — peptides have officially entered the zeitgeist. But for every breathless testimonial, there is a thicket of regulations that most market participants barely understand.

Birgit Matthiesen, Antonio J. Rivera

Rapid changes to US tariff policy have transformed what were once transactional import decisions into issues with enterprise-wide implications. The reliance on tariffs has had bipartisan support across Administrations, and the risks are not going away.

Brittany H. Sokoloff, Patricia A. Pileggi, Sean A. Worley

Individuals facing federal fraud and tax evasion charges may soon see lower advisory guideline ranges under proposed Sentencing Guidelines amendments.

David P. Grosso, Jon S. Bouker

With the release of the DC Board of Elections’ (DCBOE) official ballot for the 2026 District party primaries on June 16, the field is now set for one of the District’s most consequential local elections in the 50 years since Home Rule.

J. Michael Showalter, Alex Garel-Frantzen

Sustainability reports have become a routine part of corporate disclosures for many US companies, even though no single federal law requires them.

Clea Braendel, Matthew Galo

When the Delaware Supreme Court held in Maffei v. Palkon that Tripadvisor’s reincorporation from Delaware to Nevada should be reviewed under the business judgement rule and not the entire fairness standard (all but ensuring the company’s departure), the business community widely viewed the decision as another nail in the coffin of Delaware’s dominance of corporate formations.

Hillary M. Stemple, Gayland O. Hethcoat II, Shoshana Golden

On April 18, President Trump signed an executive order (EO) directing multiple federal agencies to accelerate research and expand access to psychedelic drugs as potential treatments for serious mental health conditions. The EO represents a notable shift in federal policy toward psychedelic substances and their potential therapeutic use.

Brian D. Schneider, David S. Greenberg, Meredith Gillespie, Sean A. Worley

The Federal Trade Commission (FTC) is signaling that health care and life sciences companies should expect heightened regulatory scrutiny related to consumer protection and competition.

D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Meghan F. Hart, Meredith Gillespie

Headlines that Matter for Companies and Executives in Regulated Industries

Robert A.H. Middleton, Amy Antoniolli, Meera Gorjala, Duncan M. Weinstein

A Will County circuit court ordered the county board to issue permits for six solar energy projects in one of the first decisions applying last month’s landmark Equity Solar appellate ruling.

Michael S. Cryan, Nardeen Billan

Imagine you are about to enter a sprawling, complex product liability multidistrict litigation (MDL) — on either side of the “v.” Hundreds of parties, a mountain of discovery, and years of litigation loom ahead. What if you could shape the case’s trajectory from day one?

Brittany H. Sokoloff, Patricia A. Pileggi, Sean A. Worley

On April 14, Jay Clayton, US attorney for the Southern District of New York (SDNY), made headlines when he announced that the US Department of Justice’s (DOJ) Corporate Enforcement and Voluntary Self-Disclosure Policy did not supersede the SDNY Corporate Enforcement Policy.

Hillary M. Stemple, Meredith Gillespie

Health care enforcement targeting diagnostic and laboratory services accelerated in 2025 and shows no signs of slowing down in 2026.

Angela M. Santos, Antonio J. Rivera, Nancy A. Noonan, Kay C. Georgi, James Kim*, Matthew Tuchband, Lucas A. Rock, Mario A. Torrico, Maya S. Cohen, Collin M. Douglas, Derek Ha, Tyler J. Kimberly, Andrew McArthur, Denny Peixoto, Riyaz Dattu*

Welcome to the April 2026 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and significant insights in an accessible format, concluding with our main takeaways — aka “And the Fox Says…” — on what you need to know.

David S. Greenberg, Katie Heilman, Hannah Z. Shlaferman

In a recent ruling out of the District of Minnesota, a federal magistrate judge directed UnitedHealthcare (UHC) to turn over an expansive set of documents in the class action Estate of Lokken v. UnitedHealth Group, Inc., alleging that the health insurer used an artificial intelligence (AI) algorithm to improperly withhold post-acute care coverage from Medicare Advantage enrollees.

Robert R. Pluth, Evgeny Magidenko

In the latest episode of “Tax Stuff You Should Know,” hosts Bob Pluth and Gene Magidenko unpack the complexities of federal self-employment tax through the lens of the Fifth Circuit’s decision in Sirius Solutions

Pamela M. Deese, Alexis Glynn

The US Federal Trade Commission’s (FTC) advance notice of proposed rulemaking is seeking industry input on delivery-fee transparency practices, which signals potential interest in broader federal regulation, underscoring the importance for online food and grocery delivery platforms and restaurant brands to assess current practices and consider participating in the comment process.

J. Michael Showalter, Isabella P. Santos

Classes of children are often named as plaintiffs in climate litigation, with complaints stressing the need for judicial intervention to overcome gridlock in the political branches.

D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Elizabeth Satarov, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

J. Michael Showalter, Kevin J. Cassato

In a significant win for the energy industry, the Maryland Supreme Court affirmed the dismissal of three municipal lawsuits alleging that energy companies engaged in deceptive practices related to the promotion of fossil fuels.

Kevin R. Pinkney, Cissy Jackson, Nadia Patel

On April 10, the US Department of Justice (DOJ) announced that International Business Machines Corporation (IBM) agreed to pay more than $17 million to resolve allegations that it violated the False Claims Act (FCA) by failing to comply with anti-discrimination requirements as set forth in Title VII of the Civil Rights Act of 1964.

Matthew F. Prewitt, Linda M. Jackson, Meghan F. Hart

Washington has joined the growing list of states that ban almost all employee noncompete agreements.

Linda M. Jackson, Matthew F. Prewitt, Meghan F. Hart, John M. Hindley, Nicole Curtis Martinez

In a significant decision, the Delaware Supreme Court reversed the dismissal of Payscale, Inc.’s breach of contract claims arising from Erin Norman’s alleged violations of the noncompete, non-solicitation, and confidentiality provisions contained in the incentive equity agreement that she signed as an employee.

Stephanie Trunk, Shoshana Golden

Last month, the US District Court for the District of Columbia struck down a 2013 policy issued by the US Department of Health and Human Services Health Resources and Services Administration (HRSA) regarding the Section 340B Drug Pricing Program “GPO prohibition” and hospital replenishment (virtual inventory) practices.

Angela M. Santos, Mario A. Torrico, Andrew McArthur

Importers now have a path to reclaim tariffs they never should have paid.